Standard BioTools Inc. Share Price
Standard BioTools Inc. (LAB) had Share Price of $1.28 per share as of 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:SharePrice · last filed 2026-03-16
- 2025-12-31: Share Price $1.28.
- 2024-12-31: Share Price $1.75.
- 2024-09-30: Share Price $1.93.
- 2024-06-28: Share Price $1.77.
| Period end | Share Price |
|---|---|
| 2025-12-31 | $1.28 10-K · filed 2026-03-16 |
| 2024-12-31 | $1.75 10-K · filed 2025-03-11 |
| 2024-09-30 | $1.93 10-Q · filed 2024-11-06 |
| 2024-06-28 | $1.77 10-Q · filed 2024-08-06 |
| 2024-05-31 | $2.40 10-Q · filed 2025-11-04 |
| 2024-03-31 | $2.71 10-Q · filed 2024-05-09 |
| 2023-12-31 | $2.21 10-K · filed 2024-03-01 |
| 2023-09-30 | $2.90 10-Q · filed 2023-11-07 |
| 2023-06-30 | $1.93 10-Q · filed 2023-08-08 |
| 2023-03-31 | $1.95 10-Q · filed 2023-05-09 |
| 2022-12-31 | $1.17 10-K · filed 2023-03-14 |
| 2022-09-30 | $1.10 10-Q · filed 2022-11-09 |
| 2022-06-30 | $1.60 10-Q · filed 2022-08-09 |
| 2022-04-04 | $3.99 10-K · filed 2023-03-14 |
| 2022-03-31 | $3.59 10-Q · filed 2023-05-09 |
| 2022-01-23 | $2.84 10-Q · filed 2023-05-09 |
| 2021-12-31 | $3.92 10-K · filed 2022-03-08 |
| 2021-09-30 | $6.59 10-Q · filed 2021-11-09 |
| 2021-06-30 | $6.16 10-Q · filed 2021-08-06 |
| 2021-03-31 | $4.52 10-Q · filed 2021-05-07 |
| 2020-12-31 | $6.00 10-K · filed 2021-02-25 |
| 2020-09-30 | $7.43 10-Q · filed 2020-11-09 |
| 2020-06-30 | $4.01 10-Q · filed 2020-08-07 |
| 2020-03-31 | $2.54 10-Q · filed 2020-05-11 |
| 2020-01-17 | $4.22 10-K · filed 2023-03-14 |
| 2019-12-31 | $3.48 10-K · filed 2020-02-27 |
| 2018-12-31 | $8.62 10-K · filed 2019-03-18 |
| 2017-12-31 | $5.89 10-K · filed 2018-03-08 |
| 2017-09-20 | $5.13 10-Q · filed 2018-11-06 |
| 2016-12-31 | $7.28 10-K · filed 2017-03-03 |
| 2015-12-31 | $10.81 10-K · filed 2016-02-29 |
| 2014-12-31 | $33.73 10-K · filed 2015-02-26 |
| 2013-12-31 | $38.28 10-K · filed 2014-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |